Related Experiment Video
Updated: Jun 30, 2026
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
Precision medicine in colorectal cancer: genomics profiling and targeted treatment
Adi Muradi Muhar1, Adrian Joshua Velaro1, Arya Tjipta Prananda1
1Department of Surgery, Faculty of Medicine, Universitas Sumatera Utara, Medan, Indonesia.
Abstract:
Precision medicine has revolutionized the treatment of colorectal cancer by enabling a personalized approach tailored to each patient's unique genetic characteristics. Genomic profiling allows for the identification of specific mutations in genes such as KRAS, BRAF, and PIK3CA, which play a crucial role in cell signaling pathways that regulate cell proliferation, apoptosis, and differentiation. This information enables doctors to select targeted therapies that inhibit specific molecular pathways, maximizing treatment effectiveness and minimizing side effects. Precision medicine also facilitates adaptive monitoring of tumor progression, allowing for adjustments in therapy to maintain treatment effectiveness. While challenges such as high costs, limited access to genomic technology, and the need for more representative genomic data for diverse populations remain, collaboration between researchers, medical practitioners, policymakers, and the pharmaceutical industry is crucial to ensure that precision medicine becomes a standard of care accessible to all. With continued advances and support, precision medicine has the potential to improve treatment outcomes, reduce morbidity and mortality rates, and enhance the quality of life for colorectal cancer patients worldwide.
Insights
Precision medicine uses genomic profiling to tailor colorectal cancer treatments, targeting specific mutations for better outcomes. Overcoming challenges like cost and data diversity is key to making this personalized approach standard care.
Area of Science:
- Oncology
- Genomics
- Pharmacology
Background:
- Colorectal cancer (CRC) treatment traditionally uses a one-size-fits-all approach.
- Genetic mutations significantly influence CRC development and progression.
- Targeted therapies offer potential for improved CRC management.
Purpose of the Study:
- To highlight the impact of precision medicine on colorectal cancer treatment.
- To discuss the role of genomic profiling in guiding therapy selection.
- To address challenges and future directions for precision oncology in CRC.
Main Methods:
- Genomic profiling to identify actionable mutations (e.g., KRAS, BRAF, PIK3CA).
- Selection of targeted therapies based on identified molecular alterations.
- Adaptive monitoring of tumor progression for treatment adjustments.
Main Results:
- Personalized treatment strategies improve therapeutic effectiveness in CRC.
- Targeted therapies minimize side effects compared to conventional treatments.
- Genomic data guides selection of optimal treatment pathways for individual patients.
Conclusions:
- Precision medicine revolutionizes colorectal cancer care through personalized, genomics-guided strategies.
- Addressing challenges in cost, access, and data diversity is essential for widespread adoption.
- Collaboration is crucial to establish precision medicine as standard CRC care, improving patient outcomes and quality of life.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...